QA: REVIVA PHARMACEUTICALS HOLDINGS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001742927_2023_REVIVA_PHARMACEUTICALS_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001742927, REVIVA PHARMACEUTICALS HOLDINGS INC.

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 18,923,675
4 LiabilitiesCurrent 6,039,840
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 567,439
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,358,734
9 ResearchAndDevelopmentExpense 18,947,874
10 remainder_Expenses 20,777
11 remainder_Revenues 0
12 remainder_NetIncome -11,907
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 18,923,675
1 Liabilities 6,607,279
2 Expenses 24,327,385
3 Revenues 0
4 StockholdersEquity 12,316,396
5 NetIncome -24,339,292
6 ComprehensiveNetIncome -24,339,292
7 BaseVar 24,935,123
8 EconomicCapitalRatio -0.247

Edgar->Model Mapping

Feature Distribution

Change over Time